nodes	percent_of_prediction	percent_of_DWPC	metapath
Nonoxynol-9—PTGS2—urinary bladder cancer	0.724	1	CbGaD
Nonoxynol-9—PTGS2—Cisplatin—urinary bladder cancer	0.133	0.504	CbGbCtD
Nonoxynol-9—PTGS2—Etoposide—urinary bladder cancer	0.131	0.496	CbGbCtD
Nonoxynol-9—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—urinary bladder cancer	0.000887	0.0793	CbGpPWpGaD
Nonoxynol-9—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—urinary bladder cancer	0.000761	0.0681	CbGpPWpGaD
Nonoxynol-9—PTGS2—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.000517	0.0462	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—PTCRA—urinary bladder cancer	0.000415	0.0371	CbGpPWpGaD
Nonoxynol-9—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—GSTO2—urinary bladder cancer	0.000403	0.036	CbGpPWpGaD
Nonoxynol-9—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC19A1—urinary bladder cancer	0.000313	0.028	CbGpPWpGaD
Nonoxynol-9—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—PRSS3—urinary bladder cancer	0.000305	0.0273	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.000294	0.0263	CbGpPWpGaD
Nonoxynol-9—PTGS2—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000275	0.0246	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000237	0.0212	CbGpPWpGaD
Nonoxynol-9—PTGS2—S1P1 pathway—RHOA—urinary bladder cancer	0.000229	0.0205	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—BIRC3—urinary bladder cancer	0.00021	0.0187	CbGpPWpGaD
Nonoxynol-9—PTGS2—Overview of nanoparticle effects—CXCL8—urinary bladder cancer	0.000201	0.018	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—MPO—urinary bladder cancer	0.000179	0.016	CbGpPWpGaD
Nonoxynol-9—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—urinary bladder cancer	0.000178	0.0159	CbGpPWpGaD
Nonoxynol-9—PTGS2—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000173	0.0154	CbGpPWpGaD
Nonoxynol-9—PTGS2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000163	0.0145	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000143	0.0128	CbGpPWpGaD
Nonoxynol-9—PTGS2—Overview of nanoparticle effects—TNF—urinary bladder cancer	0.00014	0.0125	CbGpPWpGaD
Nonoxynol-9—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—urinary bladder cancer	0.000137	0.0123	CbGpPWpGaD
Nonoxynol-9—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—urinary bladder cancer	0.000134	0.012	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000125	0.0111	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000123	0.011	CbGpPWpGaD
Nonoxynol-9—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—urinary bladder cancer	0.000122	0.0109	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—NCOR1—urinary bladder cancer	0.000112	0.01	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—GSTM1—urinary bladder cancer	0.000112	0.01	CbGpPWpGaD
Nonoxynol-9—PTGS2—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000109	0.0097	CbGpPWpGaD
Nonoxynol-9—PTGS2—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000104	0.00925	CbGpPWpGaD
Nonoxynol-9—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—urinary bladder cancer	9.64e-05	0.00862	CbGpPWpGaD
Nonoxynol-9—PTGS2—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	9.55e-05	0.00854	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	9.41e-05	0.00841	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	9.35e-05	0.00836	CbGpPWpGaD
Nonoxynol-9—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—urinary bladder cancer	9.29e-05	0.0083	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	8.95e-05	0.008	CbGpPWpGaD
Nonoxynol-9—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—urinary bladder cancer	8.88e-05	0.00794	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	8.52e-05	0.00761	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	8.28e-05	0.0074	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—CREBBP—urinary bladder cancer	7.72e-05	0.0069	CbGpPWpGaD
Nonoxynol-9—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	7.58e-05	0.00678	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	7.53e-05	0.00673	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	7.42e-05	0.00663	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	7.39e-05	0.00661	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	7.26e-05	0.00649	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	6.91e-05	0.00618	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	6.86e-05	0.00613	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	6.76e-05	0.00605	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—CDK4—urinary bladder cancer	6.74e-05	0.00603	CbGpPWpGaD
Nonoxynol-9—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—urinary bladder cancer	6.47e-05	0.00578	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	5.99e-05	0.00535	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	5.88e-05	0.00526	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—RB1—urinary bladder cancer	5.86e-05	0.00524	CbGpPWpGaD
Nonoxynol-9—PTGS2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	5.83e-05	0.00521	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—CCND1—urinary bladder cancer	5.71e-05	0.00511	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	5.53e-05	0.00494	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—RHOA—urinary bladder cancer	5.32e-05	0.00476	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—EP300—urinary bladder cancer	5.26e-05	0.0047	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	5.21e-05	0.00466	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—GSTO2—urinary bladder cancer	4.77e-05	0.00427	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—CXCL8—urinary bladder cancer	4.67e-05	0.00418	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	4.61e-05	0.00412	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	4.59e-05	0.0041	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—MYC—urinary bladder cancer	4.58e-05	0.0041	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	4.57e-05	0.00408	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—IL2—urinary bladder cancer	4.47e-05	0.00399	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—CCND1—urinary bladder cancer	4.35e-05	0.00389	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—KRAS—urinary bladder cancer	4.24e-05	0.00379	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—MMP9—urinary bladder cancer	4.23e-05	0.00378	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—GSTZ1—urinary bladder cancer	4.22e-05	0.00377	CbGpPWpGaD
Nonoxynol-9—PTGS2—Selenium Micronutrient Network—TNF—urinary bladder cancer	4.11e-05	0.00368	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	4e-05	0.00358	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—NAT1—urinary bladder cancer	4e-05	0.00357	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—GSTO2—urinary bladder cancer	4e-05	0.00357	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	3.95e-05	0.00353	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.93e-05	0.00351	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—SLC19A1—urinary bladder cancer	3.71e-05	0.00332	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—UGT2B7—urinary bladder cancer	3.65e-05	0.00327	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—PRSS3—urinary bladder cancer	3.62e-05	0.00323	CbGpPWpGaD
Nonoxynol-9—PTGS2—C-MYB transcription factor network—HRAS—urinary bladder cancer	3.6e-05	0.00322	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—MYC—urinary bladder cancer	3.49e-05	0.00312	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—HDAC4—urinary bladder cancer	3.45e-05	0.00308	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—EGFR—urinary bladder cancer	3.42e-05	0.00305	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	3.35e-05	0.003	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—CYP4B1—urinary bladder cancer	3.29e-05	0.00294	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—TNF—urinary bladder cancer	3.25e-05	0.00291	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—SLC19A1—urinary bladder cancer	3.11e-05	0.00278	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—PRSS3—urinary bladder cancer	3.03e-05	0.00271	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.96e-05	0.00265	CbGpPWpGaD
Nonoxynol-9—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	2.87e-05	0.00256	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.87e-05	0.00256	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.86e-05	0.00256	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—LIG1—urinary bladder cancer	2.74e-05	0.00245	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.73e-05	0.00244	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.65e-05	0.00237	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.43e-05	0.00217	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—TYMP—urinary bladder cancer	2.42e-05	0.00216	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.38e-05	0.00212	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.33e-05	0.00208	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.32e-05	0.00208	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.21e-05	0.00198	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.2e-05	0.00196	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—NAT2—urinary bladder cancer	2.19e-05	0.00196	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—ENO2—urinary bladder cancer	2.09e-05	0.00187	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—RBX1—urinary bladder cancer	1.98e-05	0.00177	CbGpPWpGaD
Nonoxynol-9—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.95e-05	0.00174	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—RRM2—urinary bladder cancer	1.89e-05	0.00169	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—JAG1—urinary bladder cancer	1.77e-05	0.00159	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—HPGDS—urinary bladder cancer	1.75e-05	0.00156	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—ENO2—urinary bladder cancer	1.75e-05	0.00156	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.74e-05	0.00156	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—GSTT1—urinary bladder cancer	1.7e-05	0.00152	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.67e-05	0.00149	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—NQO1—urinary bladder cancer	1.41e-05	0.00126	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—NCOR1—urinary bladder cancer	1.29e-05	0.00115	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—ERCC2—urinary bladder cancer	1.21e-05	0.00109	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.19e-05	0.00107	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—GSTP1—urinary bladder cancer	1.18e-05	0.00105	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—MTHFR—urinary bladder cancer	1.14e-05	0.00102	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.14e-05	0.00102	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—TERT—urinary bladder cancer	1.14e-05	0.00102	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—TYMS—urinary bladder cancer	1.09e-05	0.000978	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—NCOR1—urinary bladder cancer	1.08e-05	0.000967	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—GSTM1—urinary bladder cancer	1.08e-05	0.000967	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—FGFR3—urinary bladder cancer	1.04e-05	0.000934	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—GPX1—urinary bladder cancer	1.04e-05	0.000926	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—ERCC2—urinary bladder cancer	1.02e-05	0.000909	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—MTHFR—urinary bladder cancer	9.56e-06	0.000854	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—CREBBP—urinary bladder cancer	8.89e-06	0.000795	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—RHOA—urinary bladder cancer	8.04e-06	0.000719	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—PPARG—urinary bladder cancer	7.75e-06	0.000693	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—CREBBP—urinary bladder cancer	7.44e-06	0.000666	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—ERBB2—urinary bladder cancer	7.44e-06	0.000666	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—CDKN1A—urinary bladder cancer	6.36e-06	0.000569	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—PTEN—urinary bladder cancer	6.35e-06	0.000568	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—EP300—urinary bladder cancer	6.05e-06	0.000541	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—SRC—urinary bladder cancer	5.89e-06	0.000526	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—PTEN—urinary bladder cancer	5.32e-06	0.000475	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—MYC—urinary bladder cancer	5.28e-06	0.000472	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—EGFR—urinary bladder cancer	5.16e-06	0.000461	CbGpPWpGaD
Nonoxynol-9—PTGS2—Metabolism—EP300—urinary bladder cancer	5.07e-06	0.000453	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—KRAS—urinary bladder cancer	4.87e-06	0.000436	CbGpPWpGaD
Nonoxynol-9—PTGS2—Disease—HRAS—urinary bladder cancer	4.14e-06	0.00037	CbGpPWpGaD
